Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy

scientific article published on 01 June 1997

Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0008-6215(97)00084-0
P698PubMed publication ID9228737

P2093author name stringS Sheng
R Cherniak
P2860cites workCarbohydrate dynamics at a micellar surface: GD1a headgroup transformations revealed by NMR spectroscopy.Q34115335
Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.Q35390183
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.Q35409786
Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.Q35567548
Cryptococcus neoformans. 3. Inhibition of phagocytosis.Q36845787
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).Q37290596
Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophilsQ37351685
Polysaccharide antigens of the capsule of Cryptococcus neoformansQ39859915
Capsular Polysaccharides of Cryptococcus neoformansQ40112336
Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformansQ58663623
Heteronuclear NMR studies of 13C-labeled yeast cell wall beta-glucan oligosaccharides.Q64960424
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopyQ67589353
Complete assignment of the 1H- and 13C-n.m.r. spectra of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype BQ67889821
Serogroup distribution of Cryptococcus neoformans in patients with AIDSQ68162790
Glucuronoxylomannan of Cryptococcus neoformans serotype C: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopyQ68234219
Serotypes of Cryptococcus neoformans in patients with AIDSQ68861781
The variety of Cryptococcus neoformans in patients with AIDSQ68917658
Cryptococcosis in the acquired immunodeficiency syndromeQ69907540
Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-DQ69923123
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype AQ70188107
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopyQ70840109
Decreased virulence in stable, acapsular mutants of cryptococcus neoformansQ71441160
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopyQ71744863
Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDSQ72692144
P4510describes a project that usesNMR spectroscopyQ10359898
P433issue1-2
P921main subjectCryptococcus neoformansQ131924
spectroscopyQ483666
NMR spectroscopyQ10359898
P304page(s)33-40
P577publication date1997-06-01
P1433published inCarbohydrate ResearchQ2937927
P1476titleStructure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy
P478volume301

Reverse relations

cites work (P2860)
Q33755667Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy
Q33560210Cas3p belongs to a seven-member family of capsule structure designer proteins
Q36662728Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides
Q33991281Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
Q36431950Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure
Q73745163Isolation and characterization of non-labeled and 13C-labeled mannans from Pichia pastoris yeast
Q35783648Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.
Q33766799Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.
Q35641032Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule
Q74838549Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67
Q32071791Structure of the capsular polysaccharide of Clostridium perfringens Hobbs 10 determined by NMR spectroscopy

Search more.